2,026
Views
49
CrossRef citations to date
0
Altmetric
Research Paper

Vaccination against Human Papilloma Virus infection in male adolescents: Knowledge, attitudes, and acceptability among parents in Italy

, , , &
Pages 2536-2542 | Received 29 May 2014, Accepted 24 Jul 2014, Published online: 30 Oct 2014

References

  • Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine. Recommendations of the Advisory Committee on Immunization. MMWR Recomm Rep 2007; 56:1-24; PMID:17380109
  • Villa LL, Ault KA, Giuliano AR, Costa RL, Petta CA, Andrade RP, Brown DR, Ferenczy A, Harper DM, Koutsky LA et al. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine 2006; 24:5571-83; PMID:16753240; http://dx.doi.org/10.1016/j.vaccine.2006.04.068
  • GlaxoSmithKline Vaccine HPV-007 Study Group. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)–16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet 2009; 374:1975-85; PMID:19962185; http://dx.doi.org/10.1016/S0140-6736(09)61567-1
  • FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356:1915-27; PMID:17494925; http://dx.doi.org/10.1056/NEJMoa061741
  • Brisson M, Van de Velde N, Boily MC. Economic evaluation of human papillomavirus vaccination in developed countries. Pub Health Genomics 2009; 12:343-51; http://dx.doi.org/10.1159/000214924
  • Gillison ML, Broutian T, Pickard RKL, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307:693-703; PMID:22282321; http://dx.doi.org/10.1001/jama.2012.101
  • Kane MA. Preventing cancer with vaccines: progress in the global control of cancer. Cancer Prev Res 2012; 5:24-9; http://dx.doi.org/10.1158/1940-6207.CAPR-11-0533
  • Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 2011; 364:401-11; PMID:21288094; http://dx.doi.org/10.1056/NEJMoa0909537
  • Goldstone SE, Jessen H, Palefsky JM, Giuliano AR, Moreira ED Jr, Vardas E, Hillman RJ, Ferris DG, Coutlee F, Marshall JB et al. Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. Vaccine 2013; 31:3849-55; PMID:23831322; http://dx.doi.org/10.1016/j.vaccine.2013.06.057
  • Food and Drug Administration. Highlights of prescribing information. Gardasil (human papillomavirus quadrivalent [types 6, 11, 16 and 18]). Silver Spring, MD: Food and Drug Administration. 2011. Available from: http://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm111263.pdf. Accessed April 13, 2012.
  • CDC. Recommendations on the use of quadrivalent human papillomavirus vaccine in males - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 2011; 60:1705-8. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6050a3.htm. Accessed Apr 24, 2013; PMID:22189893
  • Brisson M, van de Velde N, Franco EL, Drolet M, Boily MC. Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity. J Infect Dis 2011; 204:372-6; PMID:21742835; http://dx.doi.org/10.1093/infdis/jir285
  • Georgousakis M, Jayasinghe S, Brotherton J, Gilroy N, Chiu C, Macartney K. Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study. Lancet Infect Dis 2012; 12:627-34; PMID:22445354; http://dx.doi.org/10.1016/S1473-3099(12)70031-2
  • Bosch FX, Castellsagué X, de Sanjosé S. HPV and cervical cancer: screening or vaccination? Br J Cancer 2008; 98:15-21; PMID:18182975; http://dx.doi.org/10.1038/sj.bjc.6604146
  • Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ. Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16, 18 vaccination. J Natl Cancer Inst 2008; 100:308-20; PMID:18314477; http://dx.doi.org/10.1093/jnci/djn019
  • Olshen E, Woods ER, Austin SB, Luskin M, Bauchner H. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 2005; 37:248-51; PMID:16109349; http://dx.doi.org/10.1016/j.jadohealth.2005.05.016
  • Brabin L, Roberts SA, Kitchener HC. A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent. BMC Public Health 2007; 7:20; PMID:17291343; http://dx.doi.org/10.1186/1471-2458-7-20
  • Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 2006; 117:1486-93; PMID:16651301; http://dx.doi.org/10.1542/peds.2005-1381
  • Dinh TA, Rosenthal SL, Doan ED, Trang T, Pham VH, Tran BD, Tran VD, Phan GA, Chu HK, Breitkopf CR. Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine. J Adolesc Health 2007; 40:559-63; PMID:17531763; http://dx.doi.org/10.1016/j.jadohealth.2007.02.003
  • Marlow LA, Waller J, Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine 2007; 25:1945-52; PMID:17284337; http://dx.doi.org/10.1016/j.vaccine.2007.01.059
  • Di Giuseppe G, Abbate R, Liguori G, Albano L, Angelillo IF. Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer 2008; 99:225-9; PMID:18628763; http://dx.doi.org/10.1038/sj.bjc.6604454
  • Kahn JA, Rosenthal SL, Hamann T, Bernstein DI. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS 2003; 14:300-6; PMID:12803935; http://dx.doi.org/10.1258/095646203321605486
  • Moreira ED, Oliveira BG, Ferraz FM, Costa S, Costa Filho JO, Karic G. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention. Int J Gynecol Cancer 2006; 16:599-603; PMID:16681732; http://dx.doi.org/10.1111/j.1525-1438.2006.00377.x
  • Kahn JA, Zimet GD, Bernstein DI, Riedesel JM, Lan D, Huang B, Rosenthal SL. Pediatricians’ intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 2005; 37:502-10; PMID:16310128; http://dx.doi.org/10.1016/j.jadohealth.2005.07.014
  • Riedesel JM, Rosenthal SL, Zimet GD, Bernstein DI, Huang B, Lan D, Kahn JA. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 2005; 18:391-8; PMID:16338604; http://dx.doi.org/10.1016/j.jpag.2005.09.004
  • Duval B, Gilca V, McNeil S, Dobson S, Money D, Gemmill IM, Sauvageau C, Lavoie F, Ouakki M. Vaccination against human papillomavirus: a baseline survey of Canadian clinicians’ knowledge, attitudes and beliefs. Vaccine 2007; 25:7841-7; PMID:17923173; http://dx.doi.org/10.1016/j.vaccine.2007.08.041
  • Ogilvie GS, Remple VP, Marra F, McNeil SA, Naus M, Pielak K, Ehlen T, Dobson S, Patrick DM, Money DM. Intention of parents to have male children vaccinated with the human papillomavirus vaccine. Sex Transm Infect 2008; 84:318-23; PMID:18445636; http://dx.doi.org/10.1136/sti.2007.029389
  • Lee Mortensen G. Parental attitudes towards vaccinating sons with human papillomavirus vaccine. Dan Med Bull 2010; 57:A4230; PMID:21122463
  • Reiter PL, McRee A, Gottlieb SL, Brewer NT. HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure. Vaccine 2010; 28:6292-7; PMID:20637770; http://dx.doi.org/10.1016/j.vaccine.2010.06.114
  • Sherris J, Friedman A, Wittet S, Davies P, Steben M, Saraiya M. Chapter 25: Education, training, and communication for HPV vaccines. Vaccine 2006; S3/210-8.
  • Pavia M, Foresta MR, Carbone V, Angelillo IF. Influenza and pneumococcal immunization in the elderly: knowledge, attitudes, and practices among general practitioners in Italy. Public Health 2003; 117:202-7; PMID:12825471; http://dx.doi.org/10.1016/S0033-3506(03)00066-0
  • Manuti B, Rizza P, Bianco A, Nobile CGA, Pavia M. The quality of preventive health care delivered to adults: results from a cross-sectional study in Southern Italy. BMC Public Health 2010; 10:350; PMID:20565822; http://dx.doi.org/10.1186/1471-2458-10-350
  • Zimet GD, Rosenthal SL. HPV vaccine and males: issues and challenges. Gynecol Oncol 2010; 117:26-31; http://dx.doi.org/10.1016/j.ygyno.2010.01.028
  • Liddon N, Hood J, Wynn BA, Markowitz LE. Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health 2010; 46:113-23; http://dx.doi.org/10.1016/j.jadohealth.2009.11.199
  • Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007; 45:107-14; PMID:17628649; http://dx.doi.org/10.1016/j.ypmed.2007.05.013
  • Nyhan B, Reifler J, Richey S, Freed GL. Effective messages in vaccine promotion: a randomized trial. Pediatrics 2014; 133:e835-42; PMID:24590751; http://dx.doi.org/10.1542/peds.2013-2365
  • McRee A, Reiter PL, Chantala K, Brewer NT. Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability? Cancer Epidemiol Biomarkers Prev 2010; 19:1937-44; PMID:20647398; http://dx.doi.org/10.1158/1055-9965.EPI-09-1287
  • Stata Corporation: Stata reference manual. Release 11. College Station TX; 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.